WATI

Sickle Cell Disease and Transfusion Dependent Beta-Thalassemia Treatment

We are looking to invite Haematologists to share their experience and opinions, so a newly developed interactive visual aid (IVA) can be optimised to support a potential new product launch in sickle cell disease and transfusion dependent beta-thalassemia. The client will choose some of the participants for the Phase 2 based on the feedback provided during the interviews – it will be up to you to decide if you want to proceed or not. If you are interested in taking part in this important study, please click below and apply.

  • Location: UK, Nationwide
  • Date: From 8th May onwards
  • Time: To be agreed over the phone
  • Duration: 75 minutes
  • Incentive: £160
  • Availability: 10 slots available